Herein, we appliedthis approach to site-specifically radiolabel trastuzumab-derivedFab immunoconjugates with 68Ga, which can be used for invivo PET imaging of HER2-positive breast cancer tumors. Here, ERBB2 is linked to breast carcinoma.